Aortic Aneurysm Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com

Share Article

RnRMarketResearch.com adds “Aortic Aneurysm – Pipeline Review, H1 2015” to its store. The report provides an overview of the Aortic Aneurysm’s therapeutic pipeline.

Aortic Aneurysm Therapeutic Pipeline Market

Aortic Aneurysm Therapeutic Pipeline Market

Past News Releases

RSS

The report “Aortic Aneurysm – Pipeline Review, H1 2015” provides comparative analysis on the therapeutic development for Aortic Aneurysm. The aorta is the artery that carries blood from the heart to the rest of the body. An aneurysm in the aorta is called an aortic aneurysm, which can result in death if it causes this main artery to burst and is not treated in time. When an aneurysm ruptures, you experience pain, dizziness, nausea, vomiting, clammy skin, rapid heart rate, shock or plunging blood pressure. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Complete report with TOC is available @ http://www.rnrmarketresearch.com/aortic-aneurysm-pipeline-review-h1-2015-market-report.html .

The report also reviews key players involved in the therapeutic development for Aortic Aneurysm and special features on late-stage and discontinued projects. Companies discussed in this Aortic Aneurysm – Pipeline Review, H1 2015 report include AstraZeneca PLC, Carolus Therapeutics, Inc., Eli Lilly and Company, Novartis AG and Vida Therapeutics Inc.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Drug Profiles mentioned in this report are BSN-9083, canakinumab, CT-2009, LY-3000328, Monoclonal Antibody to Inhibit Granzyme B for Aortic Aneurysm, Recombinant Protein to Inhibit Granzyme B for Cardiovascular and Dermatology Diseases and ticagrelor. Order a purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=314360 . (This is a premium report priced at US$2000 for a single user License.)

List of Tables
Number of Products under Development for Aortic Aneurysm, H1 2015 7
Number of Products under Development for Aortic Aneurysm - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Clinical Stage Development, H1 2015 10
Comparative Analysis by Early Stage Development, H1 2015 11
Comparative Analysis by Unknown Stage Development, H1 2015 12
Products under Development by Companies, H1 2015 13
Aortic Aneurysm - Pipeline by AstraZeneca PLC, H1 2015 14
Aortic Aneurysm - Pipeline by Carolus Therapeutics, Inc., H1 2015 15
Aortic Aneurysm - Pipeline by Eli Lilly and Company, H1 2015 16
Aortic Aneurysm - Pipeline by Novartis AG, H1 2015 17
Aortic Aneurysm - Pipeline by Vida Therapeutics Inc., H1 2015 18
Assessment by Monotherapy Products, H1 2015 19
Number of Products by Stage and Target, H1 2015 21
Number of Products by Stage and Mechanism of Action, H1 2015 23
Number of Products by Stage and Route of Administration, H1 2015 25
Number of Products by Stage and Molecule Type, H1 2015 27
Aortic Aneurysm Therapeutics - Recent Pipeline Updates, H1 2015 39
Aortic Aneurysm - Dormant Projects, H1 2015 47

List of Figures
Number of Products under Development for Aortic Aneurysm, H1 2015 7
Number of Products under Development for Aortic Aneurysm - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Assessment by Monotherapy Products, H1 2015 19
Number of Products by Top 10 Targets, H1 2015 20
Number of Products by Stage and Top 10 Targets, H1 2015 21
Number of Products by Top 10 Mechanism of Actions, H1 2015 22
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 23
Number of Products by Top 10 Routes of Administration, H1 2015 24
Number of Products by Stage and Top 10 Routes of Administration, H1 2015 25
Number of Products by Top 10 Molecule Types, H1 2015 26
Number of Products by Stage and Top 10 Molecule Types, H1 2015 27

Explore more reports on Therapeutics industry at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics .

About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ritesh Tiwari
@RnRMR
since: 06/2012
Follow >
RnR Market Research
Like >
Follow us on
Visit website